Literature DB >> 25744834

[Protective effect of hydrogen sulfide on rats with myocardial ischemia/reperfusion injury and its mechanism].

Yansheng Zhang1, Liangyu Peng1, Xiaohua Yu1.   

Abstract

OBJECTIVE: To explore the protective effect of hydrogen sulfide (H2S) on rats with myocardial ischemia/reperfusion injury (MIRI) and its related mechanism.
METHODS: Thirty male SD rats were randomly divided into 3 groups: control group, model group and H2S-treated group (n=10 in each). The MIRI model was established by ligating left anterior descending coronary artery for 40 minutes followed by reperfusion for 2 hours. Rats in H₂S-treated group were injected with 14 μmol/kg sodium hydrosulfide (NaHS) intraperitoneally before ischemia and reperfusion, respectively. After 24 hours of reperfusion, blood was collected from abdominal aorta and serum was separated. Then, the heart was removed. The myocardial histopathological changes were observed using HE staining. Serum levels of creatine kinase MB isozyme (CK-MB), lactate dehydrogenase (LDH) and cardiac troponin I (cTnI), as well as the activities of malondialdehyde (MDA), superoxide dismutase (SOD), glutathione-peroxidase (GSH-Px) and catalase (CAT) in the homogenate of myocardium were examined using the kits. Myocardial interleukin (IL)-1β, IL-6, IL-18 and tumor necrosis factor-α (TNF-α) contents were detected by ELISA. The levels of intracytoplasm Keap 1 and intranuclear nuclear factor-erythroid 2-related factor 2 (Nrf2) and nuclear factor-κB (NF-κB) p65 in myocardium were measured using Western blotting.
RESULTS: H₂S administration markedly relieved the pathological injury of myocardium. In comparison with control group, serum CK-MB, LDH and cTnI levels, myocardial MDA activities, nuclear factor erythroid 2-related factor 2 (Nrf2) and NF-κB p65 levels in the nucleus, and myocardial contents of IL-1β, IL-6, IL-18 and TNF-α were significantly elevated, whereas myocardial SOD, GSH-Px and CAT activities as well as Keap 1 level in the cytoplasm were significantly reduced in model group. After H₂S treatment, serum CK-MB, LDH and cTnI levels, myocardial MDA activities, Keap 1 level in the cytoplasm, myocardial contents of IL-1β , IL-6, IL-18 and TNF-α, and NF-κB p65 levels in the nucleus decreased, but myocardial SOD, GSH-Px and CAT activities, and Keap 1 level in the cytoplasm increased as compared with model group.
CONCLUSION: Exogenous H₂S could confer protection against MIRI in mice. The mechanism might be related to the enhancement of antioxidative ability and the decrease of inflammatory factor release.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25744834

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  5 in total

1.  CIRBP protects H9C2 cells against myocardial ischemia through inhibition of NF-κB pathway.

Authors:  T Y Long; R Jing; F Kuang; L Huang; Z X Qian; T L Yang
Journal:  Braz J Med Biol Res       Date:  2017-03-23       Impact factor: 2.590

2.  Effects of propofol on the inflammatory response during robot-assisted laparoscopic radical prostatectomy: a prospective randomized controlled study.

Authors:  Go Un Roh; Young Song; Junbeom Park; Yu Min Ki; Dong Woo Han
Journal:  Sci Rep       Date:  2019-03-27       Impact factor: 4.379

3.  Ginkgo biloba extract-761 protects myocardium by regulating Akt/Nrf2 signal pathway.

Authors:  Xiao-Jie Chen; Shu-Min Ren; Jian-Zeng Dong; Chun-Guang Qiu; Ying-Wei Chen; Hai-Long Tao
Journal:  Drug Des Devel Ther       Date:  2019-02-13       Impact factor: 4.162

4.  The Protective Effects of Hydrogen Sulfide New Donor Methyl S-(4-Fluorobenzyl)-N-(3,4,5-Trimethoxybenzoyl)-l-Cysteinate on the Ischemic Stroke.

Authors:  Jing Fan; Junxi Du; Zhongwei Zhang; Wenjing Shi; Binyan Hu; Jiaqin Hu; Yan Xue; Haipeng Li; Wenjin Ji; Jian Zhuang; Pengcheng Lv; Kui Cheng; Kun Chen
Journal:  Molecules       Date:  2022-02-25       Impact factor: 4.411

Review 5.  Hydrogen Sulfide (H2S)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases.

Authors:  Lei Zhang; Yanan Wang; Yi Li; Lingli Li; Suowen Xu; Xiaojun Feng; Sheng Liu
Journal:  Front Pharmacol       Date:  2018-09-21       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.